Showing results (131-140 of 155) with videos related to
Sort By:
Pageof 16
Urological Research|January 1, 1994
Immunoscintigraphy with iodine-131-labelled monoclonal antibody AUA1 in patients with transitional cell carcinoma of the bladderJ Zorzos, D V Skarlos, P Pozatzidou, et al.Cancer|October 25, 1991
Coordinate elevation of serum markers in ovarian cancer but not in benign diseaseR C Bast, S Knauf, A Epenetos, et al.British Journal of Cancer|May 1, 1985
Monoclonal antibody assay of serum placental alkaline phosphatase in the monitoring of testicular tumoursA A Epenetos, A J Munro, D F Tucker, et al.Nuclear Medicine Communications|December 1, 1987
Antibody-guided irradiation of hepatic metastases using intrahepatically administered radiolabelled anti-CEA antibodies with simultaneous and reversible hepatic blood flow stasis using biodegradable starch microspheresA A Epenetos, N Courtenay-Luck, B Dhokia, et al.British Journal of Cancer|July 1, 1982
Detection of human cancer in an animal model using radio-labelled tumour-associated monoclonal antibodiesA A Epenetos, C C Nimmon, J Arklie, et al.International Journal of Cancer|March 14, 2007
Decreased intraperitoneal disease recurrence in epithelial ovarian cancer patients receiving intraperitoneal consolidation treatment with yttrium-90-labeled murine HMFG1 without improvement in overall survivalAngèle L Oei, René H Verheijen, Michael V Seiden, et al.British Medical Journal (Clinical Research Ed.)|December 13, 1986
Imaging thrombus with radiolabelled monoclonal antibody to plateletsA M Peters, J P Lavender, S G Needham, et al.The British Journal of Cancer. Supplement|July 1, 1990
Intraperitoneally administered 90Y-labelled monoclonal antibodies as a third line of treatment in ovarian cancer. A phase 1-2 trial: problems encountered and possible solutionsV Hird, J S Stewart, D Snook, et al.In Vivo (Athens, Greece)|September 1, 1988
High dose chemotherapy with autologous bone marrow rescue in small cell lung cancerC Wilson, D Pickering, S Stewart, et al.European Journal of Nuclear Medicine|November 18, 1998
Imaging of metastatic melanoma utilising a technetium-99m labelled RGD-containing synthetic peptideG B Sivolapenko, D Skarlos, D Pectasides, et al.Pageof 16